← Return to Multifocal Adenocarcinoma of the lung, continual recurrences

Discussion

Multifocal Adenocarcinoma of the lung, continual recurrences

Lung Cancer | Last Active: Jan 17 5:58pm | Replies (436)
Comment receiving replies
@merpreb

@lls8000- Lumakras was only approved for people who have KRAS G12C and mutation prevalence in squamous NSCLC. Not plain KRAS

Jump to this post

Replies to "@lls8000- Lumakras was only approved for people who have KRAS G12C and mutation prevalence in squamous..."
Lisa, Volunteer Mentor | @lls8000 | Nov 9, 2021

Ahh, got it. There are so many variations. We certainly need more research and advances, we’ve come a long way, but have so far to go too. Hugs.

VIEW AND REPLY
jamineibs | @jamineibs | Nov 10, 2021

I will have to take a look at the type of KRAS I have and I did also wonder if the approval was based on staging. Now that I have surgery behind me for the nodules that we’re growing/changing, I can be armed with many questions after my next scan in Dec. thank you for comments.

VIEW AND REPLY